ArticlePLoS genetics2025
Novel insights into post-myocardial infarction cardiac remodeling through algorithmic detection of cell-type composition shifts.
Article in PLoS genetics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Article
- Genome-wide association mapping and targeted loss of function studies identifyProceedings of the National Academy of Sciences of the United States of America · 2026Article
- Article
- Transcriptional remodeling of cardiomyocytes and fibroblasts during post-myocardial infarction recovery.Scientific reports · 2026Article
- Decoding cardiac metabolic reprogramming through single-cell multi-omics: from mechanisms to therapeutic applications.Frontiers in cell and developmental biology · 2025Review
Corrections and comments
- Update of
Authors and funding
14 authors.
Funding
Abstract
Interpreting bulk RNA sequencing from heterogeneous tissues like the post-myocardial infarction (MI) heart is confounded by dynamic changes in cell-type composition. To address this, we developed a computational approach using single-nucleus RNA sequencing (snRNA-seq) references to estimate and correct for cell-type abundance shifts in bulk transcriptomic data. We applied this method to analyze infarct border zone transcriptomes from wild-type (WT) and cardiomyocyte-specific α1A-adrenergic receptor knockout (cmAKO) mice subjected to MI via left coronary artery ligation or sham surgery. Our analysis revealed exaggerated cardiomyocyte loss and fibroblast gain in cmAKO mice post-MI compared to WT, implicating α1A-ARs in maintaining cellular homeostasis. We then demonstrate the confounding effect of composition changes though simulations: a modest 10% change in the major cell type's abundance caused over 20% of transcripts to appear as differentially expressed genes (DEGs) when composition was ignored. Applying our correction method refined the interpretation of MI-induced transcriptomic changes, attributing many apparent DEGs, particularly those related to metabolism and inflammation, to shifts in cell abundance rather than direct transcriptional regulation. Importantly, the correction also unveiled previously masked biological processes associated with the cmAKO-specific response to MI, including pathways related to cell adhesion, cell cycle regulation, and stress response, highlighting potential intrinsic mechanisms of α1A-AR cardioprotection. RNAscope validation supported the composition-aware findings for key genes. This work presents a robust method for dissecting bulk RNA-seq data from complex tissues and provides refined insights into the cellular and molecular roles of cardiomyocyte α1A-ARs during cardiac injury and remodeling.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.